This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
PGK1 · Western blot design guide
PGK1 Western Blot Planning Guide
Plan a PGK1 Western blot around the catalog-observed 44.6 kDa band, image-backed PA2045 evidence, HPA controls, and verified protocol records.
Evidence assembled July 2026 · For research use; verify linked source records and product datasheet before use
PGK1 Western Blot Experimental Design Guide
Expected bands, documented protocol parameters, controls and antibodies — the at-a-glance facts below, then the full design guide.
Must know before running
| Expected band | 44.6 kDa | |
| Observed band | Not reported — verify product WB image | |
| Gel | 12-15% | |
| Positive control | Kidney | |
| Negative control | Smooth muscle |
Important caveats
Reasons your observed band may differ from the expected size.
| ⓘ | Calculated mass | 44.6 kDa |
| ⓘ | Localization | Cytoplasm, cytosol / Mitochondrion matrix |
| ⓘ | Processing / PTM | Record-dependent |
| ⓘ | Reactivity | Human / Mouse / Rat |
Section 1
Real Curated PGK1 Western Blot Protocols
Start with the molecular-weight rule, then compare verified publication-derived conditions.
| Sample / lysate | Breast |
| Gel % | 12-15% |
| Load | 20-30 µg total protein per lane |
| Transfer | Semi-dry, standard transfer |
| Membrane | 0.45 µm PVDF |
| Blocking | 5% non-fat milk or 5% BSA in TBST |
| Primary | PA2045 at datasheet starting dilution |
| Primary incubation | Overnight at 4 °C with gentle agitation |
| Secondary | Species-matched HRP conjugate at validated dilution |
| Wash | 3 × 5 min in TBST |
| Detection | Chemiluminescent substrate |
| Exposure | Bracket exposures to avoid saturation |
Section 2
What Is the Expected PGK1 Western Blot Band Size?
Use the product-observed 44.6 kDa band as the primary planning value and retain the UniProt calculated mass as context.
| 44.6 kDa | Matches the authoritative product WB observation. |
| 44.6 kDa calculated | Use as UniProt context, not as a replacement observed band. |
| Unexpected additional signal | Do not assign identity without orthogonal positive/negative controls. |
💡Expected PGK1 appearancePlan around 44.6 kDa and keep the calculated mass as supporting context.
| Catalog-observed band | 44.6 kDa; use this as the primary experimental expectation. |
| Calculated mass | 44.6 kDa from UniProt P00558; retain as context. |
| Gel selection | 12-15%; shared with the recommended protocol and poster. |
| Specificity check | Compare the lead HPA positive and negative controls with PA2045. |
| Situation | Likely cause | Next action |
|---|---|---|
| 44.6 kDa | Matches the authoritative product WB observation. | Confirm with orthogonal controls and the linked product record. |
| Additional band | May reflect processing, modification, or non-specific signal. | Run a dilution series and compare positive/negative controls. |
| Weak signal | Target abundance or transfer may be limiting. | Verify transfer, increase positive-control abundance, and bracket exposure. |
Experiment evidence
Western blot images showing PGK1 band
PA2045 · PGK1
← swipe / scroll for more images →
Real WB data behind the band-size expectations in this section.
Sample controls for PGK1 Western blot
🧪Use Kidney as the first positive-control candidate and Smooth muscle as the HPA Not detected negative candidate.
Positive control: Kidney (High)
Negative control: Smooth muscle (Not detected)
HPA protein score determines control status; other expression data is supporting context only.
HPA tissue expression evidence for PGK1
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
Positive expression · recommended positive controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Kidney | Reported tissue cells | High | Protein (HPA) | HPA → |
| Gallbladder | Reported tissue cells | High | Protein (HPA) | HPA → |
| Cervix | Reported tissue cells | High | Protein (HPA) | HPA → |
| Breast | Reported tissue cells | High | Protein (HPA) | HPA → |
Undetected expression · recommended negative controls
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Smooth muscle | Reported tissue cells | Not detected | Protein (HPA) | HPA → |
Section 3
Advanced PGK1 Western Blot Tips
Deeper troubleshooting and optimisation questions for PGK1, answered from its protein features.
Which band should guide the blot?
Use 44.6 kDa, the observation attached to the authoritative PA2045 WB record.
How should calculated mass be interpreted?
Treat the UniProt calculated mass as context; it does not replace the catalog-observed 44.6 kDa expectation.
Which positive control should I start with?
Start with Kidney, the lead HPA protein-expression candidate.
Which negative control is defensible?
Use Smooth muscle as an orthogonal HPA Not detected candidate.
Which gel should I use?
Use 12-15% consistently across the quick facts, protocol table, and poster.
What transfer method to use for PGK1 Western blot?
Use the transfer method in the recommended protocol and verify transfer before blocking.
How should PA2045 be started?
Start at the linked datasheet condition and run a three-point primary-antibody dilution test.
Which publication-derived protocols can I compare?
No verified publication protocol was supplied; use only the deterministic recommended protocol.
Boster reagents
PGK1 Western Blot Reagents
Human/Mouse/Rat-reactive PGK1 Western blot reagents with authoritative product imagery.
Real WB data
Anti-Phosphoglycerate kinase 1 PGK1 Antibody Picoband®
Cat # PA2045
Real WB data
Anti-PGK1 Antibody Picoband®
Cat # PB9774
Only image-backed, WB-validated Human/Mouse/Rat recommendations from the prepared catalog evidence are shown.
Source: prepared picoband-wb product evidence; each card retains its own SKU, URL, observed band, and authoritative WB image.
References
- UniProt P00558
- Human Protein Atlas — PGK1
- PA2045 product record
- PMC8419167 — PTCSC3-mediated glycolysis suppresses thyroid cancer progression via interfering with PGK1 degradation (Journal of cellular and molecular medicine, 2021)
- PMC4565669 — Insulin and mTOR Pathway Regulate HDAC3-Mediated Deacetylation and Activation of PGK1 (PLoS biology, 2015)
- PMC12177104 — Hypoxia-induced PGK1 expression promotes esophageal squamous cell carcinoma progression via stimulating MYH9-mediated GSK3β/β-catenin signalling (Clinical and translational medicine, 2025)